SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

PiperJaffray Maintains Overweight on Inovio Pharmaceuticals, Lowers Price Target to $8

PiperJaffray analyst Christopher Raymond maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $10 to $8.

Benzinga · -

PiperJaffray analyst Christopher Raymond maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Overweight and lowers the price target from $10 to $8.